News

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating ...
Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to ...
Merck & Co., Inc. (NYSE:MRK) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald ...
In the latest close session, Merck (MRK) was down 3.31% at $78.28. This change lagged the S&P 500's daily loss of 0.84%. Meanwhile, the Dow lost 0.7%, and the Nasdaq, a tech-heavy index, lost 0.91%.
The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...
Company scales leadership to accelerate growth and reinforce market position as the leader in AI-powered life sciences ...
The pending deal was rumored overnight after a report from the Financial Times, spurring analysts to speculate that if true, ...
Fat steers and heifers filled the pens at the Finney County Fairgrounds in the early morning hours of June 3, waiting to be ...
The Israel-Iran clash seemingly has no end in sight — a prospect that does not seem to be panicking the markets.
At the Heart in Diabetes CME Conference, speakers highlighted four recent reports published in the Journal of the American ...
With Viatris taking home the biggest prize at this year’s Cannes Pharma Lions award and Biogen winning Gold, pharma is making ...